Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Rodig

Showing results (111-120 of 293) with videos related to

Pageof 30
Sort By:
Elife|July 24, 2013
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancyStefan Heinrichs, Lillian F Conover, Carlos E Bueso-Ramos, et al.
Haematologica|November 13, 2012
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphomaJeffrey A Barnes, Eric Jacobsen, Yang Feng, et al.
Haematologica|June 23, 2018
Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studiesMara M Epstein, Bernard Rosner, Elizabeth C Breen, et al.
Cancer Immunology Research|June 18, 2015
Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal AdenocarcinomaSarah Derks, Katie S Nason, Xiaoyun Liao, et al.
Molecular Cancer Research : MCR|December 10, 2013
NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growthShannon T Bailey, Penelope L Miron, Yoon J Choi, et al.
Cancer Research|October 30, 2010
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancersTakaaki Sasaki, Katsuhiro Okuda, Wei Zheng, et al.
Cancer Immunology Research|October 11, 2022
Hippo Signaling Pathway Regulates Cancer Cell-Intrinsic MHC-II ExpressionZexian Zeng, Shengqing Stan Gu, Nofal Ouardaoui, et al.
American Journal of Hematology|September 18, 2007
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1Scott J Rodig, Ethan G Payne, Barbara A Degar, et al.
Nature Cancer|June 22, 2023
High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkersJia-Ren Lin, Yu-An Chen, Daniel Campton, et al.
Cell Stem Cell|February 8, 2011
Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cellsKian Peng Koh, Akiko Yabuuchi, Sridhar Rao, et al.
Pageof 30

Showing results (111-120 of 293) with videos related to

Sort By:
Pageof 30
Elife|July 24, 2013
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancyStefan Heinrichs, Lillian F Conover, Carlos E Bueso-Ramos, et al.
Haematologica|November 13, 2012
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphomaJeffrey A Barnes, Eric Jacobsen, Yang Feng, et al.
Haematologica|June 23, 2018
Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studiesMara M Epstein, Bernard Rosner, Elizabeth C Breen, et al.
Cancer Immunology Research|June 18, 2015
Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal AdenocarcinomaSarah Derks, Katie S Nason, Xiaoyun Liao, et al.
Molecular Cancer Research : MCR|December 10, 2013
NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growthShannon T Bailey, Penelope L Miron, Yoon J Choi, et al.
Cancer Research|October 30, 2010
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancersTakaaki Sasaki, Katsuhiro Okuda, Wei Zheng, et al.
Cancer Immunology Research|October 11, 2022
Hippo Signaling Pathway Regulates Cancer Cell-Intrinsic MHC-II ExpressionZexian Zeng, Shengqing Stan Gu, Nofal Ouardaoui, et al.
American Journal of Hematology|September 18, 2007
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1Scott J Rodig, Ethan G Payne, Barbara A Degar, et al.
Nature Cancer|June 22, 2023
High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkersJia-Ren Lin, Yu-An Chen, Daniel Campton, et al.
Cell Stem Cell|February 8, 2011
Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cellsKian Peng Koh, Akiko Yabuuchi, Sridhar Rao, et al.
Pageof 30